GAD-7 Anxiety Test - Generalized Anxiety Disorder Screening

The Generalized Anxiety Disorder 7-item (GAD-7) scale is one of the most widely used and validated screening tools for generalized anxiety disorder (GAD) and other anxiety conditions. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and colleagues in 2006, the GAD-7 was designed to be a brief, practical instrument that can be self-administered by patients or used by clinicians in primary care and mental health settings. The scale consists of 7 questions that assess how often a person has been bothered by specific anxiety symptoms over the past two weeks, using a 4-point Likert scale ranging from 0 ("Not at all") to 3 ("Nearly every day"). Total scores range from 0 to 21, with higher scores indicating greater anxiety severity. The GAD-7 has demonstrated excellent reliability (Cronbach alpha = 0.92) and good sensitivity (89%) and specificity (82%) for detecting generalized anxiety disorder at a cutoff score of 10. Beyond GAD, the scale has also shown utility in screening for panic disorder, social anxiety disorder, and post-traumatic stress disorder, making it a versatile tool in mental health assessment.

To complete the GAD-7, respond to each of the 7 questions by selecting how often you have been bothered by each symptom over the past 2 weeks. The response options are: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. After answering all 7 questions, your total score is calculated by summing all responses. For example, if you answered: Question 1 = 2, Question 2 = 3, Question 3 = 1, Question 4 = 2, Question 5 = 1, Question 6 = 2, Question 7 = 1, your total score would be 2+3+1+2+1+2+1 = 12, indicating moderate anxiety. The scoring ranges are: 0-4 (minimal anxiety), 5-9 (mild anxiety), 10-14 (moderate anxiety), and 15-21 (severe anxiety).

The GAD-7 score provides a snapshot of anxiety severity over the past two weeks. A score of 0-4 suggests minimal anxiety that is within normal limits. A score of 5-9 indicates mild anxiety that may cause some discomfort but is generally manageable with self-care strategies. A score of 10-14 represents moderate anxiety that is clinically significant and warrants professional evaluation. A score of 15-21 indicates severe anxiety that likely impacts daily functioning and requires active treatment. It is important to note that the GAD-7 is a screening tool, not a diagnostic instrument. A high score does not automatically mean you have an anxiety disorder, and a low score does not guarantee the absence of anxiety problems. Scores should be interpreted in the context of the individual's overall clinical presentation, including functional impairment, duration of symptoms, and co-occurring conditions. Additionally, the GAD-7 primarily screens for generalized anxiety disorder but may not fully capture symptoms of other anxiety disorders such as specific phobias, obsessive-compulsive disorder, or separation anxiety disorder. For a definitive diagnosis, a comprehensive clinical evaluation by a qualified mental health professional is necessary.

Several other validated tools exist for assessing anxiety alongside or instead of the GAD-7. The Beck Anxiety Inventory (BAI) is a 21-item self-report measure that focuses more on somatic and cognitive symptoms of anxiety, making it useful for differentiating anxiety from depression. The State-Trait Anxiety Inventory (STAI) distinguishes between state anxiety (current feelings) and trait anxiety (general tendency), providing a more nuanced assessment. The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered 14-item scale widely used in research settings. The Penn State Worry Questionnaire (PSWQ) specifically measures the tendency toward excessive worry, a core feature of GAD. The Anxiety Sensitivity Index (ASI) assesses fear of anxiety-related sensations and is particularly useful for panic disorder screening. For specific anxiety disorders, specialized tools include the Social Phobia Inventory (SPIN) for social anxiety, the Panic Disorder Severity Scale (PDSS) for panic disorder, the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for OCD, and the PTSD Checklist (PCL-5) for post-traumatic stress disorder. The PHQ-9 (Patient Health Questionnaire-9) is often used alongside the GAD-7 to screen for co-occurring depression, as anxiety and depression frequently overlap. A comprehensive mental health assessment typically combines multiple tools with clinical interviews for the most accurate evaluation.

Anxiety disorders show significant variation across demographic groups. Women are approximately twice as likely as men to be diagnosed with generalized anxiety disorder, with lifetime prevalence rates of about 7.7% for women compared to 4.6% for men. This gender difference emerges during adolescence and persists throughout life. Hormonal factors, including fluctuations in estrogen and progesterone, contribute to increased vulnerability during puberty, the premenstrual period, pregnancy, postpartum, and perimenopause. Age influences both the presentation and prevalence of anxiety. Anxiety disorders typically first appear in childhood or early adulthood, with the median age of onset for GAD being 31 years. In older adults, anxiety may present differently, often co-occurring with medical conditions, cognitive decline, or depression, and may be misattributed to normal aging. Cultural background significantly affects how anxiety is experienced and expressed. Some cultures emphasize somatic symptoms (headaches, stomach problems) over psychological symptoms (worry, fear), which can affect GAD-7 scores. Socioeconomic factors also play a role, with individuals facing financial instability, job insecurity, or housing concerns reporting higher anxiety levels. LGBTQ+ individuals experience higher rates of anxiety disorders, largely attributed to minority stress, discrimination, and social stigma. Veterans and military personnel have elevated anxiety rates related to combat exposure and traumatic experiences. People with chronic medical conditions such as heart disease, diabetes, or chronic pain are at increased risk for anxiety disorders.